Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Demographic and biological characteristics of the study participants according to diabetes statusCharacteristicsNon-diabetic (n = 1,608 to 39.2%)Pre-diabetic (n = 1,795- 43.8%)Diabetic (n = 690 to 17%)PAge (years)49.5 ± 16.563.0 ± 13.365.8 ± 13.2 < 0.001Gender N(%) Female (%)957 (59.5%)783 (43.6%)375 (54.3%) < 0.001 Male (%)651 (40.5%)1,012 (56.4%)315 (45.7%) < 0.001Infection N(%) Yes28 (9.5%)34(11.4%)17 (14.5%)0.329 No268 (90.5%)265(88.6%)100 (85.5%)BMI (kg/m2)25.6 ± 3.329.5 ± 4.631.0 ± 4.90.261Total Cholesterol (mg/dL)187.5 ± 39.2185.3 ± 44.0172.4 ± 47.2 < 0.001HDL-C (mg/dL)55.0 ± 15.251.2 ± 15.445.0 ± 13.0 < 0.001LDL-C (mg/dL)109.3 ± 33.2105.6 ± 36.992.1 ± 37.9 < 0.001Triglycerides (mg/dL)121.4 ± 72.6150.3 ± 83.3195.6 ± 175.8 < 0.001Neutrophiles (%)59.60%59.90%62.30% < 0.001Lymphocytes (%)31.40%30.80%27.50% < 0.001Eosinophiles (%)2.80%2.90%2.70%0.135Basophiles (%) < 1% < 1% < 1%0.002Monocytes (%)5.60%5.60%4.20%0.008NLR N(%) Normal1283 (86%)1324 (84%)409 (71%) < 0.001 High215 (14%)254 (16%)164 (29%)Vitamin D (VitD) (ng/mL)29.9 ± 12.231.1 ± 12.030.4 ± 14.10.018CRP (mg/L)4.1 ± 9.37.9 ± 22.122.5 ± 49.8 < 0.001Calcium (mg/dL)9.8 ± 0.59.9 ± 0.69.8 ± 0.70.094BMI body mass index, HB A1C hemoglobin A1C, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, VitD vitamin D, CRP C-reactive proteinP < 0.05 statistically significant

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional study examined retrospectively the medical laboratory record of 4093 patients from all Lebanese regions.

Source: Abstract.

A subpopulation of 712 patients were collected from various sites, including blood, body fluids, sputum, swabs, tissues, and urine.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Prevalence of type 2 diabetes (T2D) in Lebanon: association with inflammatory and infectious clinical markers

Multiple reported designs · BMC Public Health · 2023

Original publication title

Prevalence of type 2 diabetes (T2D) in Lebanon: association with inflammatory and infectious clinical markers

Pia Chedid; Elie Salem Sokhn

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The prevalence of T2D is increasing in the Lebanese population compared to prior reports. These results should be considered to guide effective public health preventive strategies.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Diabetes is a growing health concern in the Middle East, particularly in countries with high rates of obesity and unhealthy lifestyles. Therefore, this study aimed to determine the prevalence of type 2 diabetes (T2D) in Lebanon and its association with clinical markers of inflammation and infection.

Source: Background

Abstract: What methods does the paper describe?

This cross-sectional study examined retrospectively the medical laboratory record of 4093 patients from all Lebanese regions.

Prevalence of T2D and its association with age, gender, calcium, vitamin D (VitD), neutrophils-to-lymphocytes ratio (NLR), and C-reactive protein (CRP) were determined. The prevalence of infection in a subpopulation of 712 patients tested from blood, body fluid, sputum, swab, tissue, and urine samples and its etiology was also assessed.

Source: Methods Source: Methods

Abstract: Results

Overall, 17% (n = 690) of our participants had T2D, and the mean HbA1c was 5.9% ± 1.2. Age, gender, triglycerides, NLR, and calcemia were significantly associated with T2D. The prevalence of infections in a subgroup of 712 patients was 11.1% (n = 79). Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) were the most common cause of infection, with the highest prevalence in the pre-diabetic group. Serum CRP level was significantly higher in the diabetic group than the pre-diabetic and control groups.

Diabetic patients also presented a significantly higher percentage of NLR > 3 compared to the pre-diabetic and control groups.

Source: Results

Abstract: Conclusion

The prevalence of T2D is increasing in the Lebanese population compared to prior reports. These results should be considered to guide effective public health preventive strategies.

Source: Conclusion
Authors’ abstract

Background

Diabetes is a growing health concern in the Middle East, particularly in countries with high rates of obesity and unhealthy lifestyles. Therefore, this study aimed to determine the prevalence of type 2 diabetes (T2D) in Lebanon and its association with clinical markers of inflammation and infection.

Methods

This cross-sectional study examined retrospectively the medical laboratory record of 4093 patients from all Lebanese regions.

Prevalence of T2D and its association with age, gender, calcium, vitamin D (VitD), neutrophils-to-lymphocytes ratio (NLR), and C-reactive protein (CRP) were determined. The prevalence of infection in a subpopulation of 712 patients tested from blood, body fluid, sputum, swab, tissue, and urine samples and its etiology was also assessed.

Results

Overall, 17% (n = 690) of our participants had T2D, and the mean HbA1c was 5.9% ± 1.2. Age, gender, triglycerides, NLR, and calcemia were significantly associated with T2D. The prevalence of infections in a subgroup of 712 patients was 11.1% (n = 79). Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) were the most common cause of infection, with the highest prevalence in the pre-diabetic group. Serum CRP level was significantly higher in the diabetic group than the pre-diabetic and control groups.

Diabetic patients also presented a significantly higher percentage of NLR > 3 compared to the pre-diabetic and control groups.

Conclusion

The prevalence of T2D is increasing in the Lebanese population compared to prior reports. These results should be considered to guide effective public health preventive strategies.

Publication and source details

Original title: Prevalence of type 2 diabetes (T2D) in Lebanon: association with inflammatory and infectious clinical markers

Pia Chedid; Elie Salem Sokhn

BMC Public Health · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:36:12.124719+00:00

DOI: 10.1186/s12889-023-17328-6 · PMC10725583